117 results on '"Fantini, M.C."'
Search Results
2. T.04.7: ADHERENCE TO MEDITERRANEAN DIET AND DIET QUALITY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A SINGLE CENTER, OBSERVATIONAL CASE-CONTROL STUDY
3. OC.03.9: IBD-DISK: ITALIAN TRANSLATION AND VALIDATION IN A POPULATION-BASED COHORT
4. OC.03.1: ALTERED EXPRESSION AND ENZYMATIC ACTIVITY OF XANTHINE OXIDASE IN INFLAMMATORY BOWEL DISEASE
5. OC.07.1: CROHN'S DISEASE PATIENTS WITH USTEKINUMAB-INDUCED REMISSION ARE CHARACTERIZED BY HIGH BASELINE P35 CYTOKINES SUBUNITS IN LPMC AND HIGH IL-23 RECEPTOR EXPRESSION IN THE LAMINA PROPRIA TH1 CELLS
6. T.06.1 CROHN'S DISEASE PATIENTS WITH USTEKINUMAB-INDUCED REMISSION ARE CHARACTERIZED BY HIGH BASELINE IL23 RECEPTOR EXPRESSION IN THE LAMINA PROPRIA TH1 CELLS
7. T.02.10 IRON-DEFICIENCY REFRACTORY ANEMIA (IDRA) IN SARDINIAN INFLAMMATORY BOWEL DISEASE PATIENTS: A LONGITUDINAL OBSERVATIONAL STUDY
8. T.02.3 SELECTIVE OVER-EXPRESSION OF SMAD7 IN INTESTINAL EPITHELIAL CELLS RESULTS IN BARRIER DYSFUNCTION AND ILEITIS
9. T.10.5 ALTERED EXPRESSION AND ENZYMATIC ACTIVITY OF XANTHINE OXIDASE IN ULCERATIVE COLITIS PATIENTS
10. OC.10.5 SAFETY OF ORAL MESALAMINE (5-ASA) IN GLUCOSE-6-PHOSPHATE DEHYDROGENASE-DEFICIENT ULCERATIVE COLITIS PATIENTS
11. PC.01.4 REDUCED IMMUNE RESPONSE INDUCED BY TWO DOSES OF COVID-19 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA FROM ESCAPE - AN IG-IBD STUDY
12. T.08.2 ROLE OF PNPLA3, TM6SF2 AND GCKR POLYMORPHISMS IN HEPATIC STEATOSIS IN WILSON’S DISEASE
13. T.06.8 COMPARATIVE OBJECTIVE EFFECTIVENESS OF VEDOLIZUMAB AND USTEKINUMAB IN A REAL-LIFE COHORT OF ACTIVE CROHN’S DISEASE PATIENTS FAILURE TO TNF INHIBITORS
14. OC.15.4 GENOTYPE-PHENOTYPE CORRELATION IN SARDINIAN PATIENTS WITH WILSON’S DISEASE
15. P332 Treat to target in Crohnʼs disease: ultrasonographic response is associated with better outcomes
16. Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21
17. Transforming growth factor [beta] induced FoxP3+ regulatory T cells suppress Th1 mediated experimental colitis
18. In vivo imaging of colitis and colon cancer development in mice using high resolution chromoendoscopy
19. BOC.04.1: ANALYSIS OF IMMUNOLOGICALVARIABLES IN EX VIVO TOFACITINIB-TREATED HUMAN BIOPSIES FROM ACTIVE ULCERATIVE COLITIS PATIENTS TO PREDICT CLINICAL RESPONSE (THE AVATAR STUDY).
20. P.07.11 COMPARATIVE EFFICACY OF VEDOLIZUMAB AND ADALIMUMAB AS SECOND LINE THERAPY IN ULCERATIVE COLITIS PATIENTS PREVIOUSLY TREATED WITH INFLIXIMAB
21. P.02.26 OBSERVATIONAL-LONGITUDINAL STUDY ON THE QUALITY OF LIFE IN ULCERATIVE COLITIS PATIENTS
22. P.07.2 OUTCOME IN ULCERATIVE COLITIS AFTER SWITCH FROM SUBCUTANEOUS ANTI-TNF TO INTRAVENOUS ANTI-TNF: A MULTICENTRE STUDY
23. OC.10.1 RECIPROCAL REGULATION BETWEEN SMAD7 AND SIRT1 IN THE GUT
24. OC.12.6 ULTRASONOGRAPHIC RESPONSE TO ANTI-TNFS AS POTENTIAL TREATMENT TARGET IN PATIENTS WITH CROHN'S DISEASE
25. OC.01.2: Rorgamma-T-Expressing Regulatory T Cells Sustain Colorectal Cancer Growth Through a Foxo3-Dependent Suppression of Dendritic Cell-Derived IL-6 Production
26. P.01.23 EFFICACY OF THE HEMOSTATIC POWDERS (ENDOCLOT SYSTEM AND HEMOSPRAY) IN THE GASTROINTESTINAL BLEEDING
27. OC.04.3 EXPRESSION OF TBET AND RORGAMMA-T IN REGULATORY T CELLS INFLUENCE THE INCIDENCE AND SIZE OF TUMOR MASSES IN A CAC MODEL
28. OC.04.1 SMAD7 KNOCKDOWN IN COLON CANCER CELLS ACTIVATES PROTEIN KINASE RNA-ASSOCIATED EIF2-ALPHA PATHWAY THEREBY LEADING TO CELL DEATH
29. PC.01.3 COLITIS-ASSOCIATED COLORECTAL CANCER INDUCES PHENOTYPE INSTABILITY AND EFFECTOR FUNCTIONS IN TUMOR-INFILTRATING REGULATORY T CELLS
30. PC.01.2 SMAD7 SUSTAINS COLON CANCER CELL GROWTH BY MODULATING PP1 AND EIF2-ALPHA TO REGULATE CDC25A
31. P.13.18 THE ENDOSCOPIC PERFORMANCE OF GASTROENTEROLOGY TRAINEES IN A TERTIARY GASTROINTESTINAL UNIT
32. P.04.6 ACCURACY OF SMALL INTESTINE CONTRAST ULTRASONOGRAPHY COMPARED TO MAGNETIC RESONANCE ENTEROGRAPHY IN CHARACTERIZING LESIONS IN PATIENTS WITH CROHN'S DISEASE
33. OC.05.2 TH17-RELATED CYTOKINES AND EXCESSIVE ACTIVATION OF STAT3 SUSTAIN COLORECTAL CANCER CELL GROWTH
34. P.13.10 SMAD7-MEDIATED SUPPRESSION OF IL-17A IN CD4+ T CELLS PREVENTS EARLY BUT NOT LATE STAGE COLORECTAL CANCER DEVELOPMENT
35. OC.06.2: ROLE OF INTERLEUKIN-21 IN THE GROWTH OF COLITIS-ASSOCIATED COLON CANCER
36. OC.06.1: INHIBITION OF COLITIS BY IL-25 ASSOCIATES WITH INDUCTION OF ALTERNATIVELY ACTIVATED MACROPHAGES
37. S26 Smad7 expression in T cells protects from colitis-associated colorectal cancer
38. P.59 HIGH IFN-GAMMA EXPRESSION IS REQUIRED FOR TUMOR PROTECTION IN A MODEL OF COLITIS-ASSOCIATED COLORECTAL CANCER
39. P.103 2-METHOXY-5-AMINO-N-HYDROXYBENZAMIDE, A NOVEL DERIVATIVE OF 5-AMINOSALICYLIC ACID, INDUCES DR4 AND DR5 AND ENHANCES TRAIL-INDUCED APOPTOSIS IN COLON CANCER (CC) CELLS
40. 2-14, A NOVEL DERIVATIVE OF 5-AMINOSALICYLIC ACID, INDUCES ENDOPLASMATIC RETICULUM (ER) STRESS AND PREVENTS COLITIS-ASSOCIATED COLON CANCER (CC)
41. SMAD7 EXPRESSION IN T CELLS PROTECTS FROM COLITIS-ASSOCIATED COLORECTAL CANCER
42. INTERLEUKIN (IL)-25 INHIBITS IL-12 PRODUCTION AND TH1 CELL-DRIVEN INFLAMMATION IN THE GUT
43. Synchrotron XRD and EXAFS studies on nanocrystalline ZrO2–CaO solid solutions
44. P106 5-AMINOSALYCILIC ACID (5-ASA)-MEDIATED BLOCK OF COLON CANCER CELL GROWTH IS ASSOCIATED WITH DEGRADATION OF CDC25A AND ACCUMULATION OF CELLS IN S-PHASE
45. P183 A FUNCTIONAL ROLE FOR INTERLEUKIN-21 IN PROMOTING THE SYNTHESIS OF THE T CELL CHEMOATTRACTANT, MIP-3ALPHA, BY GUT EPITHELIAL CELLS
46. P184 NF-KB CONTROLS THE EXPRESSION OF FLIP, AN INHIBITOR OF FAS-MEDIATED APOPTOSIS, IN CROHN'S DISEASE LYMPHOCYTES
47. IL-6 Signaling Promotes Tumor Growth in Colorectal Cancer
48. P288 Accuracy of small intestine contrast ultrasonography compared to magnetic resonance enterography in characterizing lesions in patients with Crohn's disease
49. Spatiotemporal Patterns of Expression of Neurotrophins and Neurotrophin Receptors in Mice Suggest Functional Roles in Testicular and Epididymal Morphogenesis1
50. IL-6 Signaling Promotes Tumor Growth in Colorectal Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.